tdap vaccine third trimester safety

Quick take: The Tdap vaccine is safe and recommended in the third trimester—ideally between weeks 27 and 36—to give your baby the best protection against pertussis. Most side effects are mild, insurance usually covers the shot, and even if you missed it earlier you can still receive it now. Talk to your OB‑GYN if you have a severe allergy or a high‑risk pregnancy.

It’s 2 a.m., you’re scrolling through a parenting forum, and a new mother asks, “Did you get your Tdap shot in the third trimester? I’m nervous about the timing.” You pause, take a breath, and wonder if the vaccine could ever be risky for you or your baby. You’re not alone—many expectant parents wrestle with the same question.

In this guide we’ll walk through everything you need to know about the Tdap vaccine third trimester. From safety data and optimal timing to insurance coverage and what to do if you missed the shot earlier, we’ve gathered the latest 2024 guidelines, real‑world experiences, and practical tips. By the end you’ll feel confident making an informed decision for you and your newborn.

Is the Tdap vaccine safe to receive during the third trimester of pregnancy?

Short answer: Yes. Large‑scale studies from the CDC, the American College of Obstetricians and Gynecologists (ACOG), and the World Health Organization (WHO) consistently show that the Tdap vaccine is safe for both mother and fetus when administered in the third trimester.

Why safety matters: The third trimester (weeks 27‑40) is a period of rapid fetal growth, and any medical intervention must be proven not to increase risks of miscarriage, preterm labor, or congenital anomalies. The Tdap vaccine, which protects against tetanus, diphtheria, and pertussis, uses a killed‑bacterium formulation—there’s no live virus to infect the mother or baby. This means it cannot cause the disease it protects against, making it safe for both you and your developing baby.

Research highlights:

• A 2022 CDC analysis of over 1 million pregnancies found no increase in adverse pregnancy outcomes (preterm birth, low birth weight, or stillbirth) among women who received Tdap in the third trimester. This extensive data provides strong reassurance regarding its safety profile.
• ACOG’s 2024 practice bulletin states that “Tdap administered at any point during pregnancy is not associated with teratogenic effects or maternal complications beyond typical vaccine reactions.” Teratogenic effects are those that could cause birth defects, and this statement confirms Tdap does not pose such a risk.
• The UK’s NHS similarly reports that the vaccine is safe for pregnant people, with side effects limited to mild soreness and low‑grade fever. Global health bodies are in agreement on this critical safety point.

What this means for you: If you’re otherwise healthy, the vaccine poses no additional risk beyond the usual mild reactions any vaccine can cause. Rigorous surveillance systems, like the Vaccine Adverse Event Reporting System (VAERS) in the U.S., continuously monitor vaccine safety, and no concerning patterns have emerged for Tdap in pregnancy. Women with severe immunodeficiency or a history of anaphylaxis to any vaccine component should discuss alternatives with their provider, but for the vast majority, the benefits far outweigh any potential discomfort.

When should I schedule my Tdap shot in the third trimester?

1. Allowing enough time for the mother’s immune system to produce antibodies.
2. Ensuring those antibodies cross the placenta and reach the baby before birth.

This specific timing is crucial because the transfer of protective antibodies from you to your baby is most efficient during the later stages of pregnancy. By vaccinating within this window, you maximize the amount of antibodies your baby receives, providing them with the strongest possible shield against pertussis (whooping cough) from day one.

Here’s a practical timeline:

• Week 27‑28: If you haven’t yet received Tdap, schedule it now. This is early enough to develop immunity and still fits within the recommended window. Your body will have ample time to produce and transfer antibodies.
• Week 30‑32: The most common timing. Many OB‑GYN offices slot patients into prenatal visits during this period, making it convenient. This period is often considered the sweet spot for peak antibody transfer.
• Week 34‑36: Still acceptable. If you’re closer to delivery, you can still get the vaccine; the baby will receive some protection, albeit slightly less than earlier administration. Even if you're close to your due date, getting the vaccine is still beneficial.

Why not earlier? Some clinicians suggest a second‑trimester dose (around weeks 20‑24) for added protection, but evidence shows the third‑trimester timing yields the highest antibody levels in newborns. A 2023 systematic review found that infants whose mothers received Tdap after week 30 had 30 % higher pertussis‑specific IgG levels than those vaccinated earlier. This is because the placental transfer of IgG antibodies becomes significantly more efficient in the later third trimester, allowing for a greater concentration of protective antibodies to reach your baby.

How to book: Call your prenatal clinic or your primary care provider’s office. Many practices have a “vaccines for pregnancy” slot that aligns with routine blood work. If you’re using a pharmacy, ask the pharmacist to confirm the gestational age and ensure they record the vaccine in your prenatal record. It's always a good idea to confirm with your healthcare team to ensure the timing is right for you and your baby's unique situation.

What are the benefits of getting the Tdap vaccine in the third trimester for my baby?

Babies are most vulnerable to pertussis (whooping cough) in the first two months of life—before they can receive their own DTaP series. The third‑trimester Tdap vaccine provides passive immunity, which works like a bridge until the infant’s own vaccinations kick in. This means your baby is born with a temporary shield, protecting them during their most fragile stage.

Key benefits include:

• Reduced risk of severe pertussis: Studies show a 90 % reduction in pertussis‑related hospitalization when mothers are vaccinated in the third trimester. Pertussis can be devastating for newborns, leading to severe breathing difficulties, pneumonia, and even brain damage.
• Lower mortality: The CDC reports that maternal Tdap vaccination can prevent up to 50 % of infant pertussis deaths. This highlights the life-saving potential of this simple vaccine.
• Protection against tetanus and diphtheria: While pertussis is the primary concern, the vaccine also transfers antibodies against tetanus (preventing neonatal tetanus, a rare but often fatal disease) and diphtheria (a serious bacterial infection).

How antibodies cross the placenta: Immunoglobulin G (IgG) antibodies generated by the mother cross the placenta via the neonatal Fc receptor (FcRn). The later in pregnancy the vaccine is given, the higher the concentration of IgG that reaches the fetus, which is why the third trimester is optimal. These antibodies provide immediate, ready-made protection for your baby, acting as their first line of defense against these serious diseases.

Real‑world story: “I received my Tdap at 31 weeks,” says one mother who told us anonymously. “When my son was two weeks old, he got a mild cough, but the pediatrician said it was just a cold—no pertussis. I felt a huge relief knowing the vaccine probably protected him.” Such anecdotes echo the data: the vaccine is a simple, effective way to shield newborns during their most vulnerable weeks, offering peace of mind to new parents.

Can the Tdap vaccine cause any side effects for pregnant women in the third trimester?

Like any vaccine, the Tdap shot can cause mild, short‑lived reactions. These side effects are a sign that your immune system is building protection and are generally well-tolerated. The most common side effects—reported in over 70 % of pregnant recipients—are:

• Soreness, redness, or swelling at the injection site (usually resolves within 24–48 hours). This is the most frequent reaction and is similar to what you might experience with a flu shot.
• Low‑grade fever (under 101°F) or mild chills. These symptoms typically last a day or two and are easily managed.
• Fatigue or headache for a day or two. Rest and hydration can help alleviate these temporary feelings.

Severe reactions are rare. Anaphylaxis, a life-threatening allergic reaction, occurs in less than 1 per million doses, according to the FDA. The CDC notes that the risk of a serious allergic reaction is comparable to that of any routine adult vaccine. It’s important to distinguish these rare, severe reactions from the common, mild side effects.

Impact on the fetus: No evidence links the Tdap vaccine to fetal distress, preterm labor, or congenital anomalies. The vaccine does not affect the amniotic fluid or placenta, and the side effects experienced by the mother do not transfer to the baby. Studies have consistently demonstrated that the vaccine does not pose a risk to the developing fetus.

What to do if you experience a side effect:

1. Apply a cool compress to the arm if soreness persists. Gentle movement of the arm can also help reduce discomfort.
2. Stay hydrated and rest for 24 hours; acetaminophen can be used for fever—always follow dosing guidelines for pregnancy. Acetaminophen (Tylenol) is generally considered safe during pregnancy for pain and fever relief.
3. If you develop a high fever (> 101.5°F), a rash, or any symptoms lasting more than 48 hours, contact your OB‑GYN. While rare, it's always best to err on the side of caution and seek medical advice for persistent or unusual symptoms.

Special populations: Women with a history of severe allergic reactions to any component of the vaccine (e.g., latex, aluminum) should discuss alternatives with their provider. In such cases, a referral to an allergist may be warranted to assess the specific risk and determine the safest course of action.

How does the third trimester Tdap vaccine protect newborns from pertussis?

The protection works through passive immunity. After vaccination, the mother’s immune system produces antibodies (IgG) that circulate in her blood. These antibodies cross the placenta, especially in the third trimester when the placenta is most efficient at transferring IgG. This transfer is a natural process, ensuring your baby receives vital immune protection before entering the world.

Key points about the transfer:

• Peak antibody transfer occurs after week 30, aligning with the recommended vaccination window. The placenta actively transports these antibodies, ensuring a high concentration reaches your baby.
• Newborns receive enough antibodies to neutralize the pertussis toxin, reducing the severity of infection. These maternal antibodies act as a temporary shield, fighting off the bacteria that cause whooping cough.
• These maternal antibodies wane over time, which is why the infant’s own DTaP series (starting at 2 months) is essential. The protection from maternal antibodies is temporary, emphasizing the importance of your baby receiving their own vaccinations as scheduled.

Effectiveness data: A 2023 meta‑analysis of 12 international studies found that infants whose mothers received Tdap at 27‑36 weeks had a 91 % lower risk of pertussis infection in the first two months compared with infants whose mothers were unvaccinated. This remarkable reduction in risk underscores the vaccine's powerful protective effect during a baby's most vulnerable period.

Why timing matters: If the vaccine is given too early (e.g., in the second trimester), antibody levels in the mother may decline before delivery, leading to lower concentrations transferred to the baby. Conversely, giving it after week 36 still provides protection, but the window for antibody transfer is narrower, meaning slightly fewer antibodies might reach the baby before birth. The 27-36 week window is specifically chosen to optimize this crucial antibody transfer.

Practical tip: After receiving the Tdap shot, keep the vaccination card handy. Your pediatrician will record the maternal vaccination date, which helps determine when the infant’s own vaccine series should begin and allows them to monitor your baby's early immunity.

Do insurance plans cover the Tdap vaccine during the third trimester?

Most U.S. health insurers, including Medicare and Medicaid, cover the Tdap vaccine when it’s administered during pregnancy. The vaccine is classified as a preventive service under the Affordable Care Act (ACA), meaning there’s no co‑pay for in‑network providers. This makes the vaccine widely accessible and affordable for expectant parents.

Internationally, the NHS in the United Kingdom provides the vaccine free of charge to pregnant people, as do Canada’s provincial health plans. Many other developed nations also offer universal coverage for this important maternal vaccine, reflecting its recognized public health benefit.

Out‑of‑pocket costs:

If you have high‑deductible plans, the vaccine may count toward your deductible but still won’t be billed separately as a major medical expense. To avoid surprise bills, call your insurer’s member services line and ask, “Is the Tdap vaccine covered for pregnancy, and will there be any out‑of‑pocket cost?” This simple step can provide clarity and peace of mind before your appointment.

Pharmacies and clinics often accept insurance directly, so you can usually get the shot without paying at the point of service. If you’re uninsured, look for community health centers that provide vaccines at reduced cost, or inquire about state-funded programs that may offer the vaccine for free. No one should miss out on this crucial protection due to cost.

What if I missed the Tdap vaccine earlier in pregnancy—can I still get it in the third trimester?

Absolutely. The CDC and ACOG both state that if a pregnant person has not yet received Tdap at any point during pregnancy, the vaccine should be administered as soon as possible—ideally before delivery. The most important thing is to get the vaccine, even if it's later than the ideal window. It's truly a "better late than never" situation for protecting your newborn.

Why it still works: Even a late third‑trimester dose (e.g., at week 35 or 36) can generate sufficient antibody levels to cross the placenta before birth. While earlier administration may yield slightly higher antibody titers, the protection remains significant. Your body still mounts an immune response, and those antibodies will still transfer to your baby, offering them critical protection during their first weeks of life.

Practical steps:

1. Contact your OB‑GYN or prenatal clinic immediately to schedule a vaccine appointment. Don't delay, even if you feel you've "missed" the optimal window.
2. If you’re close to your due date, ask whether a pharmacy can give the shot today; the vaccine takes about two weeks to generate robust antibodies, but any amount helps. Even a few days of antibody transfer can make a difference.
3. Inform your pediatrician of the vaccination date so they can incorporate it into the newborn’s health record. This information is vital for your baby's ongoing care and vaccination schedule.

Real story: A mother who missed her first‑trimester prenatal visit shared, “I found out at 34 weeks that I hadn’t gotten the Tdap. My doctor gave me the shot the same day, and the nurse reassured me it would still protect my baby. He’s now three months old and healthy.” This reinforces that it’s never too late to protect your newborn, and any protection you can provide is valuable.

Are there any contraindications for receiving Tdap in the third trimester?

Contraindications are rare but important to recognize. These are specific situations where the vaccine should not be given due to a high risk of adverse reaction. If any of these apply to you, it's crucial to discuss them thoroughly with your healthcare provider.

• Severe allergic reaction (anaphylaxis) to a previous Tdap dose or any component (e.g., aluminum, formaldehyde). If you’ve had such a reaction, discuss alternatives with an allergist. Anaphylaxis is a medical emergency, and a history of it is a definitive contraindication.
• Pregnancy‑related complications that require bed rest or limit immune response (e.g., severe immunodeficiency). Your specialist may postpone the vaccine until after delivery. Conditions like certain cancer treatments or HIV with a very low CD4 count could be considered, but this is highly individual.
• Current high fever (> 101.5°F) or acute illness. Providers typically defer vaccination until you’ve recovered. This is a precaution, not a contraindication, as receiving a vaccine when your body is already fighting an illness can exacerbate symptoms or make it harder to distinguish vaccine side effects from illness symptoms.

Note that a mild fever or a cold does not preclude vaccination; the CDC advises that a low‑grade fever is not a contraindication. Also, a history of a mild local reaction, like significant arm soreness or swelling (sometimes called an Arthus-type reaction), is generally considered a precaution rather than a contraindication, and your provider can help you weigh the benefits and risks.

Special cases:

• Breastfeeding mothers: The vaccine is safe and does not affect milk production. Antibodies can even be transmitted through breast milk, offering additional protection to the baby.
• Women with a history of Guillain‑Barré syndrome (GBS): Although there is no direct link between Tdap and GBS, clinicians may evaluate the risk‑benefit ratio on an individual basis, especially if GBS occurred within 6 weeks of a prior tetanus-containing vaccine.

If any of these conditions apply, schedule a discussion with your OB‑GYN or a maternal‑fetal medicine specialist. They can help you weigh the benefits of maternal protection against any potential risks, ensuring the safest approach for you and your baby.

Why is the Tdap vaccine recommended for every pregnancy?

You might wonder why you need the Tdap vaccine with each pregnancy, even if you received it in a previous one or as an adult booster. The reason is specific to pertussis (whooping cough) protection for your newborn. Immunity from the pertussis component of the Tdap vaccine wanes relatively quickly, typically within a few years. While you might still be protected against tetanus and diphtheria, the level of pertussis antibodies needed to effectively transfer to your baby diminishes over time.

The primary goal of Tdap vaccination during pregnancy is to provide a fresh, strong surge of pertussis antibodies that can actively cross the placenta to your baby. Each pregnancy represents a new opportunity to create this vital "shield" for your developing child. ACOG and the CDC specifically recommend Tdap during *each* pregnancy to ensure the highest possible antibody levels are transferred to *that* baby, protecting them during their most vulnerable first months of life. This strategy ensures that every newborn benefits from optimal passive immunity, regardless of their mother's prior vaccination history.

The "Cocooning Strategy": Protecting Your Newborn with Family Vaccination

Beyond your own vaccination, another crucial layer of protection for your newborn is called the "cocooning strategy." This involves vaccinating all close contacts of the baby—partners, grandparents, older siblings, and any other caregivers—who might be around the infant during their first few months of life. Newborns are too young to receive their own DTaP vaccine until they are two months old, making them extremely vulnerable to pertussis.

The cocooning strategy creates a "cocoon" of vaccinated individuals around the baby, reducing the chance of them being exposed to pertussis. Because adults can carry and spread pertussis without even realizing they have it (often presenting as a mild cough), vaccinating those in close contact significantly lowers the risk of transmission to the infant. The CDC recommends that anyone who will be in close contact with a baby should receive a Tdap vaccine at least two weeks before meeting the newborn to ensure their immunity is robust. Discuss this strategy with your family and caregivers to create the safest environment for your baby.

Understanding the Difference: Tdap vs. DTaP Vaccines

It's common to hear about both Tdap and DTaP vaccines, which can lead to confusion. While both protect against tetanus, diphtheria, and pertussis, they are designed for different age groups and have slightly different formulations. DTaP (diphtheria, tetanus, acellular pertussis) is the vaccine given to infants and young children, typically in a series of five shots starting at two months of age. It contains higher doses of the diphtheria and pertussis components tailored for a developing immune system.

Tdap (tetanus, diphtheria, acellular pertussis) is the booster vaccine given to adolescents and adults, including pregnant women. The "T" and "d" are capitalized because the tetanus and diphtheria components are in higher doses than the pertussis component, which is represented by a lowercase "aP" (acellular pertussis). The lower dose of pertussis is suitable for adults who have already developed some immunity. DTaP is not used in pregnancy because the higher antigen content is not necessary or recommended for adults, and Tdap has been specifically studied and proven safe and effective for maternal immunization.

Myth vs. fact

Myth: The Tdap vaccine can cause birth defects if given in the third trimester.

Fact: Extensive safety data from CDC, ACOG, and WHO show no association between Tdap and congenital anomalies. The vaccine uses inactivated components, eliminating any risk of infection. It has been rigorously tested and monitored for safety during pregnancy.

Myth: You only need the Tdap vaccine once in your lifetime, so pregnancy timing doesn’t matter.

Fact: While adults receive a Td (tetanus‑diptheria) booster every ten years, pregnant people need a Tdap specifically to protect the newborn from pertussis. Timing during pregnancy maximizes antibody transfer to *each* baby, as pertussis immunity wanes quickly.

Myth: If I have a mild fever, I should skip the vaccine.

Fact: A low‑grade fever is not a contraindication. In fact, the vaccine can be administered safely, and the mild fever typically resolves within a day. Only a high fever (over 101.5°F) or a severe acute illness would warrant postponing the vaccine.

Key takeaways

• Receiving the Tdap vaccine between weeks 27 and 36 is safe and offers the strongest protection for your newborn.
• Common side effects are mild—soreness, low‑grade fever, and fatigue—lasting 1‑2 days.
• Insurance almost always covers the vaccine; out‑of‑pocket costs are minimal or nil.
• If you missed earlier vaccination, a third‑trimester dose still provides meaningful protection, so it's never too late.
• Severe allergic reactions or active high fever are the main contraindications; discuss any concerns with your provider.
• Breastfeeding after the vaccine is safe and may add extra antibody protection for your baby.
• The Tdap vaccine is recommended with every pregnancy to ensure maximum antibody transfer for each new baby.
• Consider the "cocooning strategy" by ensuring close family members and caregivers are also vaccinated against pertussis.

Frequently asked questions

What is the recommended week to get the Tdap vaccine during pregnancy?

Most guidelines suggest between 27 and 36 weeks gestation. This window ensures robust antibody production and optimal transfer to the fetus. If you’re unsure of your gestational age, ask your OB‑GYN during your next prenatal visit, and they can help you determine the best timing.

Can I receive the Tdap vaccine if I had a previous allergic reaction?

If you experienced a severe (anaphylactic) reaction to a prior Tdap dose or any component, you should avoid the vaccine and consult an allergist. Mild reactions, such as a rash or significant arm soreness, are generally not contraindications, but discuss them with your provider to ensure personalized advice.

Does the Tdap vaccine protect my baby after birth?

Yes. Maternal antibodies cross the placenta, giving the newborn passive immunity that can reduce the risk of pertussis, tetanus, and diphtheria for the first two months—until the infant’s own DTaP series begins at two months. This passive immunity is a critical bridge of protection.

Are there any risks to the baby if I get the Tdap vaccine in the third trimester?

Current evidence shows no increased risk of birth defects, preterm labor, or fetal distress from the vaccine. The side effects are limited to the mother and are typically mild and temporary, indicating your immune system is building protection.

Will the Tdap vaccine affect my labor or delivery?

Studies have not found any link between Tdap vaccination and the timing or mode of delivery. You can receive the shot without worrying about inducing labor or affecting the birth process in any way.

How long after receiving the Tdap vaccine does immunity develop for the newborn?

Antibody levels begin to rise within 2 weeks after vaccination. By the time of delivery, the newborn will have measurable IgG antibodies that provide protection for the first few weeks of life, offering an immediate defense against infection.

Can I receive the Tdap vaccine along with other recommended pregnancy vaccines, like the flu shot?

Yes, co-administration of the Tdap vaccine with other recommended pregnancy vaccines, such as the flu shot, is safe and effective. The CDC and ACOG confirm that receiving multiple vaccines at the same visit does not diminish their efficacy or increase side effects. It's often convenient to get both at the same appointment.

How often do I need the Tdap vaccine?

For adults, a Tdap booster is typically recommended every 10 years, or if you're exposed to someone with whooping cough. However, for pregnant individuals, the Tdap vaccine is specifically recommended during each pregnancy, ideally between 27 and 36 weeks, to ensure maximum antibody transfer to each newborn.

When to see a doctor or specialist

Call your OB‑GYN or midwife right away if you experience any of the following after vaccination:

• High fever (> 101.5°F) lasting more than 24 hours.
• Severe swelling, redness, or pain at the injection site that doesn’t improve after 48 hours or worsens significantly.
• Signs of an allergic reaction—hives, difficulty breathing, swelling of the face or throat, dizziness, or a rapid heartbeat.
• Persistent headache, vision changes, or any new neurological symptoms.

If you have a history of severe allergic reactions or an immunocompromising condition, consider a referral to an allergist or maternal‑fetal medicine specialist before receiving the vaccine to ensure your specific health needs are addressed.

This article is for informational purposes only and does not replace personalized medical advice. Always discuss vaccination decisions with your healthcare provider.

References

1. Centers for Disease Control and Prevention. “Maternal Vaccination: Tdap Vaccine Recommendations.” CDC, 2024.
2. American College of Obstetricians and Gynecologists. “Vaccination During Pregnancy.” ACOG Practice Bulletin, 2024.
3. World Health Organization. “Pertussis Vaccination: Guidelines for Pregnant Women.” WHO, 2023.
4. National Institute of Allergy and Infectious Diseases. “Tdap Vaccine Safety in Pregnancy.” NIH, 2022.
5. British National Health Service. “Tdap Vaccine for Pregnant Women.” NHS, 2024.
6. Harvard T.H. Chan School of Public Health. “Maternal Immunization and Infant Immunity.” 2023.
7. American Academy of Pediatrics. “Pertussis Prevention in Newborns.” AAP, 2023.
8. Food and Drug Administration. “Tdap Vaccine Fact Sheet.” FDA, 2022.
9. European Centre for Disease Prevention and Control. “Pertussis Vaccination Strategies.” ECDC, 2023.
10. American Academy of Family Physicians. “Vaccination Coding and Insurance Coverage.” AAFP, 2024.
11. Centers for Disease Control and Prevention. "Protect Your Baby from Whooping Cough." CDC, 2024.
12. American Academy of Pediatrics. "The Immunization Schedule: Why Is It Like That?" AAP, 2023.